United States · FDA National Drug Code directory

Estradiol and Norethindrone Acetate

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
50742-657_b156b1fa-c3f8-42fd-a8e3-e1f9c58e0175
Product NDC
50742-657
Form
TABLET
Composition / generic term
Estradiol and Norethindrone Acetate
Labeler
Ingenus Pharmaceuticals, LLC
Marketing category
ANDA
Marketing start / end (source format)
20190403
Source listing expiry
20271231

Source-listed ingredients

  • ESTRADIOL — 1 mg/1
  • NORETHINDRONE ACETATE — .5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 BLISTER PACK in 1 CARTON (50742-657-28) / 28 TABLET in 1 BLISTER PACK · 50742-657-28
  • 6 BLISTER PACK in 1 CARTON (50742-657-68) / 28 TABLET in 1 BLISTER PACK · 50742-657-68
  • 3 BLISTER PACK in 1 CARTON (50742-657-84) / 28 TABLET in 1 BLISTER PACK · 50742-657-84

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →